WOCKHARDT Surges by 7%; BSE HEALTHCARE Index Up 2.1%
March 13, 2020 12:22 PM

WOCKHARDT share price has zoomed 7% and is presently trading at Rs 222.

Meanwhile, the BSE HEALTHCARE Index is at 12,579 (up 2.1%).

Among the top Gainers in the BSE HEALTHCARE Index today are WOCKHARDT (up 7.1%) and ABBOTT INDIA (up 5.1%).

NATCO PHARMA (down 0.1%) and DIVIS LABORATORIES (down 0.2%) are among the top losers today.

Over the last one year, WOCKHARDT has moved down from Rs 439 to Rs 222, registering a loss of Rs 217 (down 49.5%).

On the other hand, the BSE HEALTHCARE has moved down from 14,333 to 12,579, loss of 1,754 points (down 12.8%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 98.6%), J.B.CHEMICALS (up 59.2%) and DR. LAL PATHLABS LTD (up 50.0%).

What About the Benchmark Indices?

The BSE Sensex is at 33,350 (up 1.2%).

The top gainers among the BSE Sensex stocks today are SBI (up 11.4%), SUN PHARMA (up 7.9%) and HDFC (up 5.7%). Other gainers include TATA STEEL (up 4.3%) and INDUSIND BANK (up 4.1%). The most traded stocks in the BSE Sensex are SBI and ICICI BANK.

In the meantime, NSE Nifty is at 9,753 (up 1.5%). SBI (up 11.4%) and SUN PHARMA (up 8.0%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 37,536 to 33,350, registering a loss of 4,186 points (down 11.7%).

WOCKHARDT Financial Update...

WOCKHARDT net profit declined 125.0% YoY to Rs 192 million for the quarter ended December 2019, compared to a loss of Rs 769 million a year ago. Net Sales declined 16.9% to Rs 8.7 billion during the period as against Rs 10.5 billion in October-December 2018.

For the year ended March 2018, WOCKHARDT reported 36.6% increase in net profit to Rs 3.1 billion compared to net profit of Rs 2.3 billion during FY17.

Revenue of the company grew 1.9% to Rs 39 billion during FY18.

The current Price to earnings ratio of WOCKHARDT, based on rolling 12 month earnings, stands at down 19.5x.